Crestor Versus Placebo in Subjects With Heart Failure

Update Il y a 4 ans
Reference: NCT00206310

Woman and Man

Extract

The purpose of the study is to investigate if rosuvastatin, added on top of all other medicines prescribed to subjects with symptomatic systolic heart failure, reduces the combined endpoint of cardiovascular death or non-fatal myocardial infarction or non-fatal stroke (time to first event)


Inclusion criteria

  • Heart failure


Links